CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Apexigen, Inc.

For profitWebsite ↗

Also known as: Apexigen America, Inc. | Apexigen, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 14, 2020

Acquired by Pyxis on Aug 23, 2023

Timeline

2010s

Jun 1, 2010
Apexigen, Inc.— Founded

2020s

Aug 23, 2023
Pyxis— Acquired By

Drugs by trial phase (13 distinct, 12 trials)

Phase 2 (10 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (13)

NCT04495257CollaboratorPhase 1Sep 14, 2020
NCT04130854CollaboratorPhase 2Apr 24, 2020
NCT04337931Lead sponsorPhase 2Dec 16, 2019
NCT03719430CollaboratorPhase 2Mar 20, 2019
NCT03597282CollaboratorPhase 1Aug 31, 2018
NCT03502330CollaboratorPhase 1Jun 9, 2018
NCT03389802CollaboratorPhase 1Feb 2, 2018
NCT03214250CollaboratorPhase 1/Phase 2Jul 21, 2017
NCT03165994CollaboratorPhase 2Jul 1, 2017
NCT02706353CollaboratorPhase 1/Phase 2Jun 2, 2017
NCT03123783Lead sponsorPhase 1/Phase 2May 1, 2017
NCT02482168Lead sponsorPhase 1May 1, 2015
NCT02482168Study directorPhase 1May 1, 2015

Details

Founded: Burlingame, CA, US Jun 1, 2010
Last known activity: Sep 14, 2020